Testimonials
What our customers say

The Alabsi Group has been helping businesses around the world simplify even the most complicated and integrated business structures for over 30 years.
Qatar Genome Project introduces a large database of prescribing medicines that improve the health care system and help researchers innovate new theories based on the project’s information. Aiming to make Qatar a pioneering country in implementing precision medicines, we organize such a huge database containing genome sequencing and omics data, along with the phenotypic data from Qatar Biobank.
The Qatar Genome Programme (QGP) is an ambitious population-based project aiming to position Qatar among the pioneering countries in the implementation of precision medicine. The project is generating large databases combining whole genome sequencing and other omics data with the comprehensive phenotypic data collected at Qatar Biobank. The wealth of such data empowers researchers to make breakthrough discoveries as well as help policy makers to better plan for future health care directions in Qatar.
QGP was launched by Qatar Foundation with a comprehensive strategy based on seven building blocks:
The Alabsi Group is internationally recognized as a leader in helping businesses navigate the global market and combat the challenges of today’s world climate.
Studies conducted by Waleed Alabsi show that there has been an extraordinary leap in the knowledge of the human genome and its role in health and disease in recent years. It requires computational technologies to make sense of
Genomic medicine refers to the study of genes and how they interact with our health. It investigates how a person’s biological information can improve their clinical care outcomes.
Qatar Genome is the largest project in the Middle East that promotes genome sequencing to the national level for implementing precision medicine.
Qatar Genome Project makes the health care industry stronger with genomic research that helps identify risks of different diseases. Read on to know more.